Graham Capital Management’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$394K	Sell	112,831 -145,007	-56%	-$522K	0.01%	706
2025 Q4	$882K	Buy	257,838 +231,725	+887%	+$1.03M	0.02%	425
2025 Q3	$131K	Sell	26,113 -116,922	-82%	-$515K	﹤0.01%	1134
2025 Q2	$491K	Buy	+143,035	New	+$356K	0.01%	836
2025 Q1	–	Sell	-103,610	Closed	-$304K	–	1256
2024 Q4	$304K	Buy	+103,610	New	+$289K	﹤0.01%	930
2024 Q2	–	Sell	-47,551	Closed	-$215K	–	1005
2024 Q1	$215K	Sell	47,551 -27,606	-37%	-$141K	﹤0.01%	877
2023 Q4	$429K	Sell	75,157 -105,232	-58%	-$488K	0.01%	634
2023 Q3	$830K	Buy	180,389 +108,060	+149%	+$657K	0.02%	419
2023 Q2	$467K	Sell	72,329 -401,921	-85%	-$2.74M	0.01%	575
2023 Q1	$3.58M	Buy	474,250 +325,051	+218%	+$2.95M	0.11%	127
2022 Q4	$1.51M	Sell	149,199 -254,972	-63%	-$2.95M	0.05%	385
2022 Q3	$4M	Buy	404,171 +340,732	+537%	+$3.74M	0.16%	72
2022 Q2	$675K	Buy	+63,439	New	+$537K	0.03%	567
2022 Q1	–	Sell	-25,727	Closed	-$367K	–	874
2021 Q4	$367K	Buy	+25,727	New	+$390K	0.02%	254